-
Something wrong with this record ?
Hepatitis D
P. Husa, A. Linhartová, V. Němeček, L. Husová
Language English Country Slovakia
NLK
Freely Accessible Science Journals
from 2003 to 2018
Single Journals
ROAD: Directory of Open Access Scholarly Resources
from 1995
PubMed
16402678
Knihovny.cz E-resources
- MeSH
- Antiviral Agents therapeutic use MeSH
- Models, Biological MeSH
- Hepatitis B complications MeSH
- Hepatitis D * diagnosis epidemiology drug therapy complications MeSH
- Interferon-alpha therapeutic use MeSH
- Humans MeSH
- Hepatitis Delta Virus physiology pathogenicity MeSH
- Check Tag
- Humans MeSH
Hepatitis D virus (HDV) is a small, RNA-containing virus that requires the concomitant presence of Hepatitis B virus (HBV) in an obligate manner for its survival and pathogenicity. HDV infection is very uncommon in Czech Republic. The results of antiviral therapy of hepatitis D patients are not satisfactory. Alpha-interferon (alpha-IFN) in high doses (9-10 MU three times a week for 12 months) is usually recommended.
Department of Infectious Diseases University Hospital Brno Jihlavska 20 625 00 Brno Czech Republic
National Reference Laboratory for Viral Hepatitis National Institute of Health Prague
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18038252
- 003
- CZ-PrNML
- 005
- 20181120124651.0
- 007
- ta
- 008
- 181120s2005 xo abd f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)16402678
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Husa, Petr, $d 1960- $7 xx0018127 $u Department of Infectious Diseases, University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic. phusa@med.muni.cz
- 245 10
- $a Hepatitis D / $c P. Husa, A. Linhartová, V. Němeček, L. Husová
- 504 __
- $a Literatura $b 28
- 520 9_
- $a Hepatitis D virus (HDV) is a small, RNA-containing virus that requires the concomitant presence of Hepatitis B virus (HBV) in an obligate manner for its survival and pathogenicity. HDV infection is very uncommon in Czech Republic. The results of antiviral therapy of hepatitis D patients are not satisfactory. Alpha-interferon (alpha-IFN) in high doses (9-10 MU three times a week for 12 months) is usually recommended.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 02
- $a hepatitida B $x komplikace $7 D006509
- 650 02
- $a hepatitida D $x diagnóza $x epidemiologie $x farmakoterapie $x komplikace $7 D003699
- 650 12
- $a hepatitida D $7 D003699
- 650 02
- $a virus hepatitidy delta $x fyziologie $x patogenita $7 D003698
- 650 02
- $a lidé $7 D006801
- 650 02
- $a interferon alfa $x terapeutické užití $7 D016898
- 650 02
- $a biologické modely $7 D008954
- 700 1_
- $a Linhartová, A. $u National Reference Laboratory for Viral Hepatitis, National Institute of Health, Prague
- 700 1_
- $a Němeček, Vratislav, $d 1950- $7 xx0060525 $u National Reference Laboratory for Viral Hepatitis, National Institute of Health, Prague
- 700 1_
- $a Husová, Libuše $7 xx0018126 $u National Reference Laboratory for Viral Hepatitis, National Institute of Health, Prague
- 773 0_
- $p Acta Virol $t Acta Virologica $x 0001-723X $g Roč. 49, č. 4 (2005), s. 219-225 $w MED00000149
- 910 __
- $a ABA008 $b A 2823 $y 4 $z 0
- 990 __
- $a 20181120105751 $b ABA008
- 991 __
- $a 20181120124745 $b ABA008
- 999 __
- $a ok $b bmc $g 1352574 $s 1035288
- BAS __
- $a 3
- BMC __
- $a 2005 $b 49 $c 4 $d 219-225 $i 0001-723X $m Acta virologica $x MED00000149
- LZP __
- $a NLK 2018-02/jt
